Defects in mitochondrial clearance predispose human monocytes to interleukin-1β hypersecretion

J Biol Chem. 2014 Feb 21;289(8):5000-12. doi: 10.1074/jbc.M113.536920. Epub 2013 Dec 19.

Abstract

Most hereditary periodic fever syndromes are mediated by deregulated IL-1β secretion. The generation of mature IL-1β requires two signals: one that induces synthesis of inflammasome components and substrates and a second that activates inflammasomes. The mechanisms that mediate autoinflammation in mevalonate kinase deficiency, a periodic fever disease characterized by a block in isoprenoid biosynthesis, are poorly understood. In studying the effects of isoprenoid shortage on IL-1 β generation, we identified a new inflammasome activation signal that originates from defects in autophagy. We find that hypersecretion of IL-1β and IL-18 requires reactive oxygen species and is associated with an oxidized redox status of monocytes but not lymphocytes. IL-1β hypersecretion by monocytes involves decreased mitochondrial stability, release of mitochondrial content into the cytosol and attenuated autophagosomal degradation. Defective autophagy, as established by ATG7 knockdown, results in prolonged cytosolic retention of damaged mitochondria and increased IL-1β secretion. Finally, activation of autophagy in healthy but not mevalonate kinase deficiency patient cells reduces IL-1β secretion. Together, these results indicate that defective autophagy can prime monocytes for mitochondria-mediated NLRP3 inflammasome activation, thereby contributing to hypersecretion of IL-1β in mevalonate kinase deficiency.

Keywords: Autoinflammatory Disorder; Autophagy; Interleukin; Mitochondrial DNA; Monocytes; Periodic Fever; Redox Regulation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Autophagy
  • Cell Line
  • Child
  • Child, Preschool
  • Cytosol / metabolism
  • DNA, Mitochondrial / metabolism
  • Disease Susceptibility / metabolism*
  • Disease Susceptibility / pathology*
  • Humans
  • Inflammasomes / metabolism
  • Interleukin-1beta / metabolism*
  • Membrane Potential, Mitochondrial
  • Mevalonate Kinase Deficiency / metabolism
  • Mevalonate Kinase Deficiency / pathology
  • Mitochondria / metabolism*
  • Models, Biological
  • Monocytes / metabolism*
  • Monocytes / pathology*
  • Oxidation-Reduction
  • Terpenes / metabolism

Substances

  • DNA, Mitochondrial
  • IL1B protein, human
  • Inflammasomes
  • Interleukin-1beta
  • Terpenes